RemSleep Holdings Inc.
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
About RemSleep
Services-Personal Services, SIC 7200
REMSleep Holdings, Inc. develops and distributes medical devices for respiratory therapy, specializing in products for individuals suffering from obstructive sleep apnea. Its core offering is the DeltaWave CPAP interface, a patented nasal-pillows mask engineered to treat sleep apnea patients by improving user comfort and reducing the work of breathing. The company targets durable medical equipment providers, hospitals, acute care facilities, sleep laboratories, and physicians specializing in sleep and neurology, with durable medical equipment suppliers and hospitals representing its primary anticipated revenue channels.
The company operates its principal executive offices in Blackshear, Georgia. Product manufacturing utilizes molds that are currently fabricated in China, though REMSleep evaluates options to transition mold production to the United States. Its commercial activities primarily target the United States respiratory market, where products are subject to regulation by the Food and Drug Administration.
Summary of the business section of RemSleep's latest annual report, written by StockData.
Company profile
Company
- Legal name
- RemSleep Holdings Inc.
- Founded
- 2007
- Headquarters
- Clearwater, FL
- Address
- 14175 Icot Bvld. Suite 300 33760
- Phone
- (727) 955-4465
- Website
- remsleep.com
- Employees
- 2, Dec 31, 2025
- Industry
- Services-Personal Services
- Incorporated in
- Nevada
- Fiscal year ends
- December 31
- Auditor
- Fruci & Associates II, PLLC, Spokane, Washington
Stock & identifiers
- Ticker
- RMSL
- Exchange
- OTC
- IPO date
- Jul 24, 2009
- Shares outstanding
- 1.74B, Jun 30, 2026
- Public float
- $14.72M, Jun 30, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company
- Stock splits
- 1-for-20 reverse, Jun 30, 2017; 251-for-1, Feb 15, 2017; 1-for-2331 reverse, Dec 30, 2016; 1-for-2000 reverse, Mar 26, 2015
- SEC CIK
- 1412126
- CUSIP
- 75990A200
- ISIN
- US75990A2006
- LEI
- 549300FB2QHNQAIU4527
- EIN
- 38-3759675
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
No recent ownership filings by officers or directors
RemSleep's leadership is listed in its proxy statement (Form DEF 14A).
Employees
Headcount reported in annual reports
“We have two employees: Jeffrey Marshall, Chief”
Corporate history
Events identified from SEC filings